<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>4(1)</volume><submitter>Bonomo P</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Response assessment to definitive non-surgical treatment for head and neck squamous cell carcinoma (HNSCC) is centered on the role of &lt;sup>18&lt;/sup>F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET-CT) 12 weeks after treatment. The 5-point Hopkins score is the only qualitative system available for standardized reporting, albeit limited by suboptimal positive predictive value (PPV). The aim of our study was to explore the feasibility and assess the diagnostic accuracy of an experimental 6-point scale ("Cuneo score").&lt;h4>Methods&lt;/h4>We performed a retrospective, multicenter study on HNSCC patients who received a curatively-intended, radiation-based treatment. A centralized, independent qualitative evaluation of post-treatment FDG-PET/CT scans was</pubmed_abstract><journal>European journal of hybrid imaging</journal><pagination>8</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8218061</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study.</pubmed_title><pmcid>PMC8218061</pmcid><pubmed_authors>Cauda S</pubmed_authors><pubmed_authors>Belgioia L</pubmed_authors><pubmed_authors>Alterio D</pubmed_authors><pubmed_authors>Ursino S</pubmed_authors><pubmed_authors>Berretta L</pubmed_authors><pubmed_authors>Casolo A</pubmed_authors><pubmed_authors>Scalone F</pubmed_authors><pubmed_authors>Roncali M</pubmed_authors><pubmed_authors>Livi L</pubmed_authors><pubmed_authors>Belli G</pubmed_authors><pubmed_authors>Desideri I</pubmed_authors><pubmed_authors>Volterrani D</pubmed_authors><pubmed_authors>Vigo F</pubmed_authors><pubmed_authors>Russi E</pubmed_authors><pubmed_authors>Morbelli S</pubmed_authors><pubmed_authors>Bergesio F</pubmed_authors><pubmed_authors>Lopci E</pubmed_authors><pubmed_authors>Bianchi A</pubmed_authors><pubmed_authors>Bonomo P</pubmed_authors><pubmed_authors>Cicchetti S</pubmed_authors><pubmed_authors>Travaini L</pubmed_authors><pubmed_authors>Saieva C</pubmed_authors><pubmed_authors>Berti V</pubmed_authors><pubmed_authors>Merlotti A</pubmed_authors><pubmed_authors>Pirro V</pubmed_authors><pubmed_authors>Bacigalupo A</pubmed_authors><pubmed_authors>Franzese C</pubmed_authors><pubmed_authors>D'Angelo E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Does a 6-point scale approach to post-treatment 18F-FDG PET-CT allow to improve response assessment in head and neck squamous cell carcinoma? A multicenter study.</name><description>&lt;h4>Purpose&lt;/h4>Response assessment to definitive non-surgical treatment for head and neck squamous cell carcinoma (HNSCC) is centered on the role of &lt;sup>18&lt;/sup>F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET-CT) 12 weeks after treatment. The 5-point Hopkins score is the only qualitative system available for standardized reporting, albeit limited by suboptimal positive predictive value (PPV). The aim of our study was to explore the feasibility and assess the diagnostic accuracy of an experimental 6-point scale ("Cuneo score").&lt;h4>Methods&lt;/h4>We performed a retrospective, multicenter study on HNSCC patients who received a curatively-intended, radiation-based treatment. A centralized, independent qualitative evaluation of post-treatment FDG-PET/CT scans was</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 May</publication><modification>2025-04-22T15:51:40.324Z</modification><creation>2022-02-10T17:13:47.21Z</creation></dates><accession>S-EPMC8218061</accession><cross_references><pubmed>34191171</pubmed><doi>10.1186/s41824-020-00077-9</doi></cross_references></HashMap>